Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Cancer Lett. 2012 Feb 2;320(1):104–110. doi: 10.1016/j.canlet.2012.01.039

Figure 3. Compilation of CI values @ IC50 for different drug combinations in MCF-7, MB-231, and SK-BR-3 cells.

Figure 3

The CI values provide the following interpretations: <0.1 very strong synergism; 0.1 to 0.3 strong synergism, 0.3 to 0.7 synergism, 0.7 to 0.85 moderate synergism, 0.85 to 0.9 slight synergism, 0.9 to 1.10 nearly additive.